Skip to main content

Published locations for Bezlotoxumab may lower risk of C. difficile readmissions

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Bezlotoxumab may lower risk of C. difficile readmissions

User login

  • Reset your password
  • /content/bezlotoxumab-may-lower-risk-c-difficile-readmissions
  • /familypracticenews/article/146847/healthcare-acquired-infections/bezlotoxumab-may-lower-risk-c
  • /gihepnews/article/146847/hospital-acquired-infections/bezlotoxumab-may-lower-risk-c-difficile
  • /idpractitioner/article/146847/healthcare-acquired-infections/bezlotoxumab-may-lower-risk-c-difficile
  • /internalmedicinenews/article/146847/healthcare-acquired-infections/bezlotoxumab-may-lower-risk-c
  • /hospitalist/article/146847/healthcare-acquired-infections/bezlotoxumab-may-lower-risk-c-difficile
  • /infectiousdisease/article/146847/healthcare-acquired-infections/bezlotoxumab-may-lower-risk-c
  • /internalmedicine/article/146847/healthcare-acquired-infections/bezlotoxumab-may-lower-risk-c
  • /familymedicine/article/146847/healthcare-acquired-infections/bezlotoxumab-may-lower-risk-c-difficile